Gelonghui, December 28, 丨 Huajian Healthcare (01931.HK) announced that on December 28, 2023, the strategic cooperation agreement signed between Weishida, a wholly-owned subsidiary of the company, and Heathson Meikang Shanghai on strategic cooperation in the blood coagulation products business has been completed.
The strategic cooperation will strengthen the relationship between the two parties. Under normal circumstances, it is possible to effectively maintain the supply of Heathson Macron products distributed by Wisdom and maintain the regions where Westar is authorized to distribute. The strategic cooperation will also enable the two sides to utilize their respective strengths, resources and expertise to continue to develop a long-term and mutually beneficial strategic relationship with the Group and Heathson Meikang.